Literature DB >> 12486002

Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF.

Vanessa Brès1, Hideaki Tagami, Jean-Marie Péloponèse, Erwan Loret, Kuan-Teh Jeang, Yoshihiro Nakatani, Stephane Emiliani, Monsef Benkirane, Rosemary E Kiernan.   

Abstract

The HIV-1 transactivator protein, Tat, is an atypical transcriptional activator that functions through binding, not to DNA, but to a short leader RNA, TAR. Although details of its functional mechanism are still unknown, emerging findings suggest that Tat serves primarily to adapt co-activator complexes such as p300, PCAF and P-TEFb to the HIV-1 long terminal repeat. Hence, an understanding of how Tat interacts with these cofactors is crucial. It has recently been shown that acetylation at a single lysine, residue 50, regulated the association of Tat with PCAF. Here, we report that in the absence of Tat acetylation, PCAF binds to amino acids 20-40 within Tat. Interestingly, acetylation of Tat at Lys28 abrogates Tat-PCAF interaction. Acetylation at Lys50 creates a new site for binding to PCAF and dictates the formation of a ternary complex of Tat-PCAF-P-TEFb. Thus, differential lysine acetylation of Tat coordinates the interactions with its co-activators, cyclin T1 and PCAF. Our results may help in understanding the ordered recruitment of Tat co-activators to the HIV-1 promoter.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12486002      PMCID: PMC139090          DOI: 10.1093/emboj/cdf669

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  54 in total

1.  HIV-1 transcription: activation mediated by acetylation of Tat.

Authors:  Yoshihiro Nakatani
Journal:  Structure       Date:  2002-04       Impact factor: 5.006

Review 2.  Regulated assembly of transcription factors and control of transcription initiation.

Authors:  D Beckett
Journal:  J Mol Biol       Date:  2001-11-30       Impact factor: 5.469

3.  Control of formation of two distinct classes of RNA polymerase II elongation complexes.

Authors:  N F Marshall; D H Price
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

4.  Tat trans-activates the human immunodeficiency virus through a nascent RNA target.

Authors:  B Berkhout; R H Silverman; K T Jeang
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

5.  Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase.

Authors:  C H Herrmann; A P Rice
Journal:  Virology       Date:  1993-12       Impact factor: 3.616

6.  Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro.

Authors:  C Dingwall; I Ernberg; M J Gait; S M Green; S Heaphy; J Karn; A D Lowe; M Singh; M A Skinner; R Valerio
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication.

Authors:  Vanessa Brès; Rosemary Kiernan; Stéphane Emiliani; Monsef Benkirane
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

8.  Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.

Authors:  L Deng; C de la Fuente; P Fu; L Wang; R Donnelly; J D Wade; P Lambert; H Li; C G Lee; F Kashanchi
Journal:  Virology       Date:  2000-11-25       Impact factor: 3.616

9.  HIV-1 Tat protein promotes formation of more-processive elongation complexes.

Authors:  R A Marciniak; P A Sharp
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation.

Authors:  E Verdin; P Paras; C Van Lint
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  35 in total

1.  Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter.

Authors:  Marina Lusic; Alessandro Marcello; Anna Cereseto; Mauro Giacca
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

2.  Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.

Authors:  Baode Xie; Valerie Calabro; Mark A Wainberg; Alan D Frankel
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

3.  Characterization of HIV Tat modifications using novel methyl-lysine-specific antibodies.

Authors:  Sara Pagans; Naoki Sakane; Martina Schnölzer; Melanie Ott
Journal:  Methods       Date:  2010-07-06       Impact factor: 3.608

Review 4.  Functional roles of HIV-1 Tat protein in the nucleus.

Authors:  Yana R Musinova; Eugene V Sheval; Carla Dib; Diego Germini; Yegor S Vassetzky
Journal:  Cell Mol Life Sci       Date:  2015-10-27       Impact factor: 9.261

5.  Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter.

Authors:  Céline Tréand; Isaure du Chéné; Vanessa Brès; Rosemary Kiernan; Richard Benarous; Monsef Benkirane; Stéphane Emiliani
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

6.  Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency.

Authors:  Isaure du Chéné; Euguenia Basyuk; Yea-Lih Lin; Robinson Triboulet; Anna Knezevich; Christine Chable-Bessia; Clement Mettling; Vincent Baillat; Jacques Reynes; Pierre Corbeau; Edouard Bertrand; Alessandro Marcello; Stephane Emiliani; Rosemary Kiernan; Monsef Benkirane
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

Review 7.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

Review 8.  Genetic variation and function of the HIV-1 Tat protein.

Authors:  Cassandra Spector; Anthony R Mele; Brian Wigdahl; Michael R Nonnemacher
Journal:  Med Microbiol Immunol       Date:  2019-03-05       Impact factor: 3.402

9.  Regulation of human SRY subcellular distribution by its acetylation/deacetylation.

Authors:  Laurie Thevenet; Catherine Méjean; Brigitte Moniot; Nathalie Bonneaud; Nathalie Galéotti; Gudrun Aldrian-Herrada; Francis Poulat; Philippe Berta; Monsef Benkirane; Brigitte Boizet-Bonhoure
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

10.  Association of Tat with promoters of PTEN and PP2A subunits is key to transcriptional activation of apoptotic pathways in HIV-infected CD4+ T cells.

Authors:  Nayoung Kim; Sami Kukkonen; Sumeet Gupta; Anna Aldovini
Journal:  PLoS Pathog       Date:  2010-09-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.